Full Press Release Details
CARLSBAD, Calif., Nov. 1, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that it will be introducing three new products at the upcoming North American Spine Society (NASS) meeting in Chicago, IL, which will be held from November 2nd to 4th, 2011
The Company is pleased to make the following new product introductions, and to announce the release of Alphatec Solus to its international beta sites:
-- The Trestle LuxeTM Anterior Cervical Plating System is the Company's next-generation anterior cervical fixation system. It combines a proprietary zero-step locking mechanism, low-profile flush-fit design, large graft window, and a comprehensive offering of implants and instrumentation to provide the surgeon with confidence in the system's performance and comfort to their patients.
-- The AvalonTM Occipito-Cervico Plating System, which is used in connection with the Solanas Posterior Cervico-Thoracic Fixation System, provides the surgeon with an innovative and comprehensive posterior solution for occipito-cervico-thoracic fixation. The unique buttress design of the Avalon plate allows the surgeon to ideally place and secure bone graft in the optimal midline location to help promote fusion and improve graft stability without adding profile to the overall surgical construct.
-- The Epicage Minimally Invasive Posterior Interbody Spacer can be used for either TLIF or PLIF procedures. In its resting state the cage has a crescent shape; but due to its unique geometry and design, it can be flexed into a straight and narrow shape. The cage can be delivered in a minimally invasive, low- profile manner, which upon delivery reshapes to cover a large surface area. Additionally, it is delivered through a portal that is designed to reduce the potential of nerve injury to the patient, and to ensure that the cage is delivered to a precise location upon each implementation.
-- The Alphatec SolusTM Anterior Lumbar Interbody Fusion (ALIF) System provides a biomechanically proven, industry leading design in treating spinal column stability for internal fixation ALIF devices. Four points of fixation combined with what we believe is the largest competitively available graft volume support rapid and robust arthodesis potential. Deployment of the internal fixation blades is performed in one step, and is designed to decrease incision size, operative time and blood loss.
"Alphatec Spine is extremely proud to have designed, manufactured and introduced each of these products to the US and international markets", said Dirk Kuyper, President and CEO. "These products are on the cutting edge of spinal instrumentation and implants. Each incorporates our philosophy of being focused on the aging spine, being minimally invasive in their approach and compatible with Biologics solutions. Each of these systems is in a significantly sized market segment, and as next-generation designs, each has the potential to impact our future positively".
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its US operations, the Company also markets its products in over 50 international markets through its affiliate, Scient'x S.A.S., via a direct sales force in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa, South America and Latin America. In Asia, the Company markets its products through its subsidiary, Alphatec Pacific, Inc. and through distributors in the rest of the Asia Pacific region.
The Alphatec Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3520
Forward Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, the following: Alphatec Spine's ability to meet its 2011 revenue, adjusted EBITDA, free cash flow and earnings projections, the growth rate of the spine market related to aging and elderly patients, uncertainty of success in developing new products or products currently in Alphatec Spine's pipeline, the successful global launch of the Company's new products and the products in its development pipeline including Trestle Luxe, Avalon, Epicage and Alphatec Solus, and the potential of each of these products to impact the Company's future positively, failure to achieve acceptance of Alphatec Spine's products by the surgeon community, failure to obtain FDA clearance or approval for new products, or unexpected or prolonged delays in the process, Alphatec Spine's ability to develop and expand its US and/or global revenues, continuation of favorable third party payor reimbursement for procedures performed using Alphatec Spine's products, unanticipated expenses or liabilities or other adverse events affecting cash flow or Alphatec Spine's ability to successfully control its costs or achieve profitability, uncertainty of additional funding, Alphatec Spine's ability to compete with other competing products and with emerging new technologies, product liability exposure, patent infringement claims and claims related to Alphatec Spine's intellectual property. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.